Literature DB >> 12592605

Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes.

Quanhe Yang1, Muin J Khoury, Lorenzo Botto, J M Friedman, W Dana Flanders.   

Abstract

Studies have argued that genetic testing will provide limited information for predicting the probability of common diseases, because of the incomplete penetrance of genotypes and the low magnitude of associated risks for the general population. Such studies, however, have usually examined the effect of one gene at time. We argue that disease prediction for common multifactorial diseases is greatly improved by considering multiple predisposing genetic and environmental factors concurrently, provided that the model correctly reflects the underlying disease etiology. We show how likelihood ratios can be used to combine information from several genetic tests to compute the probability of developing a multifactorial disease. To show how concurrent use of multiple genetic tests improves the prediction of a multifactorial disease, we compute likelihood ratios by logistic regression with simulated case-control data for a hypothetical disease influenced by multiple genetic and environmental risk factors. As a practical example, we also apply this approach to venous thrombosis, a multifactorial disease influenced by multiple genetic and nongenetic risk factors. Under reasonable conditions, the concurrent use of multiple genetic tests markedly improves prediction of disease. For example, the concurrent use of a panel of three genetic tests (factor V Leiden, prothrombin variant G20210A, and protein C deficiency) increases the positive predictive value of testing for venous thrombosis at least eightfold. Multiplex genetic testing has the potential to improve the clinical validity of predictive testing for common multifactorial diseases.

Entities:  

Mesh:

Year:  2003        PMID: 12592605      PMCID: PMC1180239          DOI: 10.1086/367923

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'.

Authors:  P O Hansson; L Welin; G Tibblin; H Eriksson
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

2.  "Code of practice and guidance on human genetic testing services supplied direct to the public". Advisory Committee on Genetic Testing.

Authors:  J C Barber
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

3.  Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.

Authors:  R H White; H Zhou; P S Romano
Journal:  Ann Intern Med       Date:  1998-05-01       Impact factor: 25.391

4.  DNA chips give new view of classic test.

Authors:  E Pennisi
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

5.  1998 ASHG presidential address. Making genomic medicine a reality.

Authors:  A L Beaudet
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

Review 6.  The new genetics in clinical practice.

Authors:  J Bell
Journal:  BMJ       Date:  1998-02-21

7.  Predictive genetic testing: from basic research to clinical practice.

Authors:  N A Holtzman; P D Murphy; M S Watson; P A Barr
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

8.  DNA chips: analysing sequence by hybridization to oligonucleotides on a large scale.

Authors:  E M Southern
Journal:  Trends Genet       Date:  1996-03       Impact factor: 11.639

9.  Likelihood ratios for continuous test results--making the clinicians' job easier or harder?

Authors:  D L Simel; G P Samsa; D B Matchar
Journal:  J Clin Epidemiol       Date:  1993-01       Impact factor: 6.437

10.  Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.

Authors:  P M Ridker; R J Glynn; J P Miletich; S Z Goldhaber; M J Stampfer; C H Hennekens
Journal:  Ann Intern Med       Date:  1997-04-01       Impact factor: 25.391

View more
  44 in total

1.  Revisiting the clinical validity of multiplex genetic testing in complex diseases.

Authors:  A Cecile J W Janssens; M Carolina Pardo; Ewout W Steyerberg; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2004-03       Impact factor: 11.025

2.  Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Authors:  Christopher E Aston; David A Ralph; Dominique P Lalo; Sharmila Manjeshwar; Bobby A Gramling; Daniele C DeFreese; Amy D West; Dannielle E Branam; Linda F Thompson; Melissa A Craft; Debra S Mitchell; Craig D Shimasaki; John J Mulvihill; Eldon R Jupe
Journal:  Hum Genet       Date:  2004-12-21       Impact factor: 4.132

Review 3.  Genetics and public health--evolution, or revolution?

Authors:  Jane L Halliday; Veronica R Collins; Mary Anne Aitken; Martin P M Richards; Craig A Olsson
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

4.  Impact of genetic testing on complex diseases.

Authors:  M J E van Rijn; C M van Duijn; A J C Slooter
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  An algorithm for model construction and its applications to pharmacogenomic studies.

Authors:  Kung-Hao Liang; Yuchi Hwang; Wan-Ching Shao; Ellson Y Chen
Journal:  J Hum Genet       Date:  2006-08-10       Impact factor: 3.172

6.  A research agenda for assessing the potential contribution of genomic medicine to tobacco control.

Authors:  Wayne D Hall
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

7.  Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes.

Authors:  Qing Lu; Robert C Elston
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

8.  Comparison of risk perceptions and beliefs across common chronic diseases.

Authors:  Catharine Wang; Suzanne M O'Neill; Nan Rothrock; Robert Gramling; Ananda Sen; Louise S Acheson; Wendy S Rubinstein; Donald E Nease; Mack T Ruffin
Journal:  Prev Med       Date:  2008-11-25       Impact factor: 4.018

9.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

Review 10.  In vivo epigenome editing and transcriptional modulation using CRISPR technology.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Transgenic Res       Date:  2018-10-04       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.